对一些抗癌药物,以脂质体为载体的体系已证实具有增加药效,降低毒性的作用。将脂质体设计成纳米体系包裹药物,有利于半衰期的延长和药物在肿瘤部位的更多聚集。尽管长春碱类抗癌药物及PEG修饰的脂质体多柔比星在临床治疗中已得到应用,但目前的“远程运载”工艺要将药物稳定包封 For some anti-cancer drugs, liposome-based systems have been shown to increase efficacy and reduce toxicity. The design of liposomes as nano-system for drug encapsulation is conducive to the extension of half-life and drug more aggregation in the tumor site. Although vinblastine-based anticancer drugs and PEG-modified liposomal doxorubicin have been used in clinical treatment, the current “long-range delivery” process involves stable encapsulation of the drug